GRI Bio Inc
GRI
Get informed when a big investor buys or sells
+ FollowMarket Cap$185.05K
Close$
$15.73
638.3% upside
Current Fair Value
638.3% upsideUndervalued by 638.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $185,054.00 |
|---|---|
| Enterprise Value | $-7,972,946.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-121.8 |
| Beta | -1.22 |
| Outstanding Shares | 1,241,000 |
Return
| Return on Equity | -196.44% |
|---|---|
| Return on Assets | -136.19% |
| Return on Invested Capital | -196.20% |
Valuation & Multiples
| P/E Ratio | -0.23 |
|---|---|
| PEG | -0.93 |
| Price to Sales | - |
| Price to Book Ratio | 0.53 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 0.67 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -0.01 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 21, 2026
EPS Estimate
$-3.74
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
August 13, 2026
EPS Estimate
$-1.20
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 2.27%▲ 2.27% |
|---|---|
| Total Invested | $64,652▲ 222837.93% |
| Investors Holding | 6▲ 5.00% |
ESG Score
No data
About GRI Bio Inc
2 employees